How many insider declarations has Doyle Janeen Noel filed?

Doyle Janeen Noel has filed 3 public insider declarations with SEC (Form 4).

What is Doyle Janeen Noel's role?

Doyle Janeen Noel's reported role is not specified by the regulator across the filings.

Which companies does Doyle Janeen Noel report trades for?

Doyle Janeen Noel reports trades for Janux Therapeutics, Inc..

What is Doyle Janeen Noel's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 49k€.

← Executives ★ Sign in to follow

DJ

Doyle Janeen Noel

F

·SEC (Form 4)

Janux Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€49,029

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Doyle Janeen Noel. Insider active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 3 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €49k. History available since 2 June 2025. The latest transaction was filed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Doyle Janeen Noel

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Janux Therapeutics, Inc. (US)

Declarations3 total

▼

Doyle Janeen Noel

Chief Corp. & Bus. Dev. OfcrExecutives2 Jun 2026Janux Therapeutics, Inc.

$56,94425SEC ↗

4,059 shares@ US$14.0290.0059% mcap100.0% of flowCommon StockSEC:0002069239-26-000005:0

◆

Doyle Janeen Noel

Chief Corp. & Bus. Dev. OfcrExecutives2 Jan 2026Janux Therapeutics, Inc.

0SEC ↗

36,000 shares0Common StockSEC:0002069239-26-000002:0

◆

Doyle Janeen Noel

Chief Corp. & Bus. Dev. OfcrExecutives2 Jun 2025Janux Therapeutics, Inc.

11SEC ↗

44,000 shares0Common StockSEC:0001415889-25-015684:0

3 of 3 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DJ

Doyle Janeen Noel

F

·SEC (Form 4)

Janux Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€49,029

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Doyle Janeen Noel. Insider active across 1 company, notably Janux Therapeutics, Inc.. Cumulatively, 3 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €49k. History available since 2 June 2025. The latest transaction was filed on 2 June 2026 (Cession). Regulator: SEC (Form 4). All data is free.